Cargando…

Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway

The coupling of Arg-Gly-Asp-Val (RGDV) and gemcitabine led to a hypothesis that the conjugate (RGDV-gemcitabine) could inhibit tumor metastasis. To confirm this hypothesis the activities of RGDV-gemcitabine inhibiting tumor metastasis in vitro and in vivo were presented for the first time. AFM (atom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoyi, Zhang, Jinhuan, Liu, Wenchao, Wang, Yaonan, Wu, Jianhui, Zhao, Shurui, Zhao, Ming, Peng, Shiqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519057/ https://www.ncbi.nlm.nih.gov/pubmed/32978501 http://dx.doi.org/10.1038/s41598-020-72824-8

Ejemplares similares

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
por: Liu, Wenchao, et al.
Publicado: (2019)

Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
por: Li, Guanyu, et al.
Publicado: (2020)

13-[CH(2)CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
por: Li, Guanyu, et al.
Publicado: (2019)

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis
por: Li, Shan, et al.
Publicado: (2015)

Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy
por: Wu, Jianhui, et al.
Publicado: (2015)

ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo
por: Wang, Yuji, et al.
Publicado: (2017)

BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral β-carboline-3-carboxylic acid
por: Wu, Jianhui, et al.
Publicado: (2019)

Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent
por: Zhu, Haimei, et al.
Publicado: (2017)

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
por: Wu, Jianhui, et al.
Publicado: (2017)

IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis
por: Wu, Jianhui, et al.
Publicado: (2017)

Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao, Shurui, et al.
Publicado: (2019)

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo
por: Xu, Xinyi, et al.
Publicado: (2017)

Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
por: Zhang, Xiaoyi, et al.
Publicado: (2020)

Initiative action of tumor-associated macrophage during tumor metastasis
por: Singh, Saroj, et al.
Publicado: (2017)

Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy
por: Jiang, Xueyun, et al.
Publicado: (2015)

Action Mechanism of Fuzheng Fangai Pill Combined with Cyclophosphamide on Tumor Metastasis and Growth
por: Liu, Sheng, et al.
Publicado: (2014)

Interferons in the management of neuroendocrine tumors and their possible mechanism of action.
por: Oberg, K.
Publicado: (1992)

Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
por: Bi, Yanzhao, et al.
Publicado: (2016)

Dimethyl 2,2′-[2,2′-(ethane-1,1-diyl)bis(1H-indole-3,2-diyl)]-diacetate: a small molecule capable of nano-scale assembly, inhibiting venous thrombosis and inducing no bleeding side effect
por: Wang, Yaonan, et al.
Publicado: (2018)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
por: Chen, Haiyan, et al.
Publicado: (2018)

IMMUNIZATION AGAINST THE ACTION OF SUBSTANCES INHIBITING TUMOR GROWTH
por: Fleisher, Moyer S., et al.
Publicado: (1914)

Intervening pyruvate carboxylase stunts tumor growth by strengthening anti-tumor actions of tumor-associated macrophages
por: Shu, Yuxin, et al.
Publicado: (2022)

Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
por: Wu, Jianhui, et al.
Publicado: (2018)

Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs
por: Tang, Lan, et al.
Publicado: (2023)

Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis
por: Chen, Haiyan, et al.
Publicado: (2017)

Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
por: Cui, Chunying, et al.
Publicado: (2013)

Exploring the possible mechanisms of action behind the antinociceptive activity of Bacopa monniera
por: Bhaskar, Manju, et al.
Publicado: (2011)

A Possible Mechanism of Action of the Chemopreventive Effects of Sarcotriol on Skin Tumor Development in CD-1 Mice
por: Kundoor, Vipra, et al.
Publicado: (2006)

Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models
por: Chen, Xiao, et al.
Publicado: (2023)

Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth
por: Cerles, Olivier, et al.
Publicado: (2019)

Discovery and characterization of actionable tumor antigens
por: Ehx, Grégory, et al.
Publicado: (2019)

The Mechanisms of Action of Tumor Treating Fields
por: Moser, Justin C., et al.
Publicado: (2022)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
por: Cuevas, Maria Virginia Ruiz, et al.
Publicado: (2023)

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
por: Bergman, Andries M., et al.
Publicado: (2010)

Autophagy regulates tumor growth and metastasis
por: Qiang, Lei, et al.
Publicado: (2023)

Translatomics to explore dynamic differences in immunocytes in the tumor microenvironment
por: Guo, Yilin, et al.
Publicado: (2023)

Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis
por: Barcus, Craig E., et al.
Publicado: (2021)

Antimutagenic compounds and their possible mechanisms of action
por: Słoczyńska, Karolina, et al.
Publicado: (2014)

Korsgaard’s Constitutivism and the Possibility of Bad Action
por: Pauer-Studer, Herlinde
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dvuv3gcl86qkfgdbm9bhm2an08